CClinicalTrials.gg
Not yet recruitingNCT07714954Updated Aug 14, 2026

Replication: Meaning-centered Intervention for Internalizing Symptoms

An interventional study of Meaning-centered intervention for individuals who tend to feel down or anxious in Depression and/or Anxiety Symptoms, sponsored by University of Groningen. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-14.

Sponsored by University of Groningen · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Young adults who experience depression and/or anxiety symptoms (i.e., internalizing symptoms) will be randomly allocated to a six-session meaning-centered intervention condition or a waitlist condition. Both conditions receive the same questionnaires at baseline, post assessment (intervention condition: immediately after the final session; waitlist: four weeks after baseline), and follow-up.

The researchers hypothesize that a meaning-centered intervention for individuals with internalizing symptoms will increase participants' meaning in life and reduce their internalizing symptoms at post assessment and 4-week follow-up when compared to a waitlist condition.

Read the detailed description

First-year psychology students at the University of Groningen will be screened for depression and anxiety symptoms. Those with heightened symptoms will be invited via e-mail to participate in the study. After filling out the baseline assessment online, participants will be randomly assigned to either a meaning-centered intervention condition, which will receive a meaning-centered intervention taking place approximately every four days, or a waitlist condition, which will be assigned no task. Participants in the intervention condition will follow six 1-hour online intervention sessions led by a trainer and conduct intervention-related homework assignments. The sessions can be followed in English, Dutch, or German. The intervention aims to increase participants' meaning in life and reduce their internalizing symptoms. Immediately after the final session (i.e. approximately one month after the baseline assessment), participants in the intervention condition will be asked to fill in the post assessment, which includes the same questionnaires as the baseline assessment. Additionally, they will be ask to provide feedback about the intervention regarding session and homework content. Participants in the waitlist control will be asked to complete the post assessment one month after their baseline assessment. One month after the post assessment, participants in both conditions are asked to fill in same set of questionnaires. Waitlist participants are offered to receive the intervention sessions after the study has finished. Participants are compensated with SONA credits. This study will replicate a previous study initially testing the meaning-centered intervention (https://clinicaltrials.gov/study/NCT07058181?aggFilters=status:,phase:\&tab=researcher#trial-description).

02

Conditions studied

  • Depression and/or Anxiety Symptoms

Keywords

  • meaning in life
  • meaning-centered intervention
  • internalizing symptoms
  • depression symptoms
  • anxiety symptoms
03

In context

Depression

8,057 studies on the registry are indexed under Depression; 1,643 are open to participants now.

This study's planned enrollment of 140 is above the median of 84 across 6,718 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

University of Groningen is the lead sponsor of 22 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • heightened internalizing symptoms (depression and/or anxiety symptoms) as indicated by PHQ-4 score of 2 or above on either the anxiety or depression subscale

Exclusion criteria

Exclusion Criteria:

  • receiving psychotherapeutic treatment for a depressive or anxiety disorder
  • suicidality
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
140 participants (estimated)

Study arms

  • Experimental
    Meaning-centered intervention

    * Participants receive a meaning-centered intervention consisting of six 1-hour online sessions led by a trainer. * Interventions: Behavioral: Meaning-centered intervention for individuals who tend to feel down or anxious

    Behavioral: Meaning-centered intervention for individuals who tend to feel down or anxious

  • No intervention
    Waitlist control

    \- No task or intervention is assigned to participants in this arm.

Interventions

  • BehavioralMeaning-centered intervention for individuals who tend to feel down or anxious

    * Six 1-hour individual online sessions, approximately every 4 days * Sessions led by a certified trainer based on intervention manual * Four sources of meaning will be explored: personal life story, dealing with life's limitations, creating one's own life, and meaningful experiences * Participants follow intervention using intervention the workbook * Homework assignments designed to deepen participants' experience and reflection on meaning in their daily lives

    Also known as: Meaning-centered intervention for internalizing symptoms adapted from the intervention "Meaning-centered intervention for youth worrying about their weight and shape".

06

What researchers measure

Primary outcomes

  1. Depression Anxiety Stress Scale (DASS-21)

    self-report questionnaire: DASS-21: sum score (0-63), 4-point Likert scale (0-3), higher scores indicating higher internalizing symptoms)

    Time frame: Time Frame: at baseline; post (one month after baseline); one-month follow-up (one month after post)

  2. Meaning in Life Questionnaire (MLQ); presence of meaning subscale

    self-report questionnaire: MLQ: sum score (5-35), 7-point Likert scale (1-7), higher scores indicating higher presence of life meaning

    Time frame: Time Frame: at baseline; post (one month after baseline); one-month follow-up (one month after post)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07714954
Lead sponsor
University of Groningen
Responsible party
Sponsor
First posted
Jul 20, 2026
Start date
Oct 2026 (estimated)
Primary completion
Feb 2028 (estimated)
Completion
Feb 2028 (estimated)
Last update
Aug 14, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion